share_log

Biolase Q1 2024 Adj EPS $(0.36) Misses $(0.17) Estimate, Sales $10.131M Beat $9.996M Estimate

Biolase Q1 2024 Adj EPS $(0.36) Misses $(0.17) Estimate, Sales $10.131M Beat $9.996M Estimate

Biolase 2024 年第一季度调整后每股收益 (0.36) 未达预期 (0.17) 美元,销售额为 1013.1 万美元,超过预期 99.96 万美元
Benzinga ·  05/14 04:07

Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.17) by 111.76 percent. The company reported quarterly sales of $10.131 million which beat the analyst consensus estimate of $9.996 million by 1.35 percent. This is a 3.21 percent decrease over sales of $10.467 million the same period last year.

Biolase(纳斯达克股票代码:BIOL)公布的季度亏损为每股0.36美元,比分析师普遍预期的0.17美元(0.17美元)低111.76%。该公司公布的季度销售额为1013.1万美元,比分析师普遍预期的999.6万美元高出1.35%。这比去年同期的1046.7万美元的销售额下降了3.21%。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发